Biomea Fusion, Inc.

As of June 30, 2026, Biomea Fusion, Inc. carries a market capitalization of 106.55M, placing it among publicly traded companies globally. Its enterprise value stands at 72.60M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Biomea Fusion, Inc.'s next confirmed earnings release is scheduled for November 3, 2026.

As of June 30, 2026, Biomea Fusion, Inc. has 72.48M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Biomea Fusion, Inc. maintains a current ratio of 3.47, meaning it holds 3.5x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Biomea Fusion, Inc. posted a negative return on equity (ROE) of -164.14, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -59.14, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 57.25, a quick read on workforce productivity versus industry peers.

As of the close on October 22, 2026, Biomea Fusion, Inc.'s stock has declined approximately 59.38% over the past 52 weeks. The 50-day moving average sits at 1.44, while the 200-day moving average is 1.40.

Over the twelve months ended June 30, 2026, Biomea Fusion, Inc. generated - - in revenue and converted that into -32.54M in net income, yielding earnings per share of -0.47. EBITDA reached -57.52M, while operating income came in at -55.86M.

As of June 30, 2026, Biomea Fusion, Inc. holds 34.82M in cash and equivalents against 877,000.00 in total debt, resulting in a net debt position of -34.82M. Total book value stands at 12.14M, with working capital of 25.95M providing operational flexibility.

Biomea Fusion, Inc. produced -47.19M in operating cash flow over the twelve months ended June 30, 2026. After subtracting - - in capital expenditures, free cash flow totaled -47.19M - equivalent to -0.68 per share.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -46.39: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -23.69, meaning Biomea Fusion, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Biomea Fusion, Inc. has an Altman Z-Score of -19.41, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.